Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Am J Chin Med. 2000;28(2):175-85.

Therapeutic effect of gypenoside on chronic liver injury and fibrosis induced by CCl4 in rats.

Author information

  • 1Research Institute of Chinese Medicine, Chinese Medical College, Taichung, Taiwan.

Abstract

Gypenoside is a saponins extract derived from the Gynostemma pentaphyllum. The purpose of this study was to evaluate the hepatoprotective and antifibrotic potential of Gypenoside on chronic liver injury induced by CCl4 for 8 wks. The results indicated that the increase of SGOT, SGPT activities in CCl4 liver injury were significantly reduced by treatment with Gypenoside. It also elevated the A/G ratio. For the study of anti-fibrotic potential, Gypenoside reduced the collagen content by 33%. These phenomena were confirmed by pathologic observation; thinner bands of liver collagen were found. The results suggest that Gypenoside has hepatoprotective and anti-fibrotic activities.

PMID:
10999436
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Atypon
    Loading ...
    Write to the Help Desk